Instrument Inactif

Communiqués XsunX Inc OTC Bulletin Board

Actions

US98385L1026

Recherche biotechnologique et médicale

Communiqués

14/01	NovAccess Global : Annual Report for Fiscal Year Ending September 30, 2024 (Form 10-K)	PU
04/06/24	NovAccess Global : Material Agreement Form 8 K	PU
30/04/24	NovAccess Global : Announces New License to Advance its Immunotherapy Platform	PU
03/01/24	NovAccess Global Announces $10.7 Million Financing	AQ
01/12/23	NovAccess Global Inc. to Present at the December 7th Virtual Investor Summit	NE
28/07/23	NovAccess Global Partners with BCN Biosciences to Expand Immunotherapy Platform	AQ
13/07/23	NovAccess Global : to Participate in National Brain Tumor Society’s Annual Glioblastoma Awareness Day	PU
23/06/23	NOVACCESS GLOBAL INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	AQ
12/06/23	NOVACCESS GLOBAL INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	AQ
12/05/23	NovAccess Global Lead Scientist Published in High-Profile Medical Journal for Cancer Vaccine Advancements	AQ
11/05/23	NovAccess Global : Lead Scientist Published in High-Profile Medical Journal for Cancer Vaccine Advancements	PU
02/05/23	NOVACCESS GLOBAL INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	AQ
18/04/23	NOVACCESS GLOBAL INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	AQ
16/03/23	NOVACCESS GLOBAL INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities (form 8-K)	AQ
15/03/23	NovAccess Global : Dr. Christopher Wheeler, NovAccess Lead Scientist, Receives Prestigious Golden Axon Award	PU
17/02/23	NovAccess Global to Present at World Orphan Drug Congress	AQ
14/02/23	NOVACCESS GLOBAL INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ
13/02/23	NOVACCESS GLOBAL INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	AQ
06/02/23	NovAccess Global Leadership to Present at World Brain Mapping Foundation Annual Congress	AQ
24/01/23	NovAccess Global : Material Agreement - Form 8-K	PU
23/01/23	NOVACCESS GLOBAL INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	AQ
10/01/23	NOVACCESS GLOBAL INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	AQ
13/12/22	NOVACCESS GLOBAL INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	AQ
23/11/22	NOVACCESS GLOBAL INC. : Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	AQ
23/11/22	NovAccess Global Announces Initial Fireside Chat with Glioblastoma Patient Advocate	AQ